Skip to content

Female Sexual Dysfunction in Renal Failure

Female Sexual Dysfunctions in Patients With Chronic Renal Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03172637
Enrollment
100
Registered
2017-06-01
Start date
2017-07-01
Completion date
2018-12-31
Last updated
2017-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluations of Sexual Dysfunction of Female in Chronic Renal Failure

Brief summary

A myriad of sexual problems affect men and women with chronic kidney disease (CKD), including decreased libido, erectile dysfunction, dysmenorrhea, and infertility. Menstrual abnormalities are common in CKD and many women are an-ovulatory . Causes of sexual dysfunction in CKD include hormonal alterations along with vascular, neurologic, psychogenic, and other factors, such as medications, contribute to the development of sexual dysfunction . Sexual dysfunction in females is mainly due to hormonal factors and manifests mainly as menstrual irregularities, amenorrhea, lack of vaginal lubrication, and failure to conceive.

Detailed description

Hormonal changes in chronic kidney disease are seen in prolactine, gonadotropins, and gonadal hormones. In women with CKD, elevated levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are common. These hormonal changes are detected in the early stages of kidney disease and progressively worsen as kidney disease progresse . . Women with chronic renal failure commonly have elevated circulating prolactin levels. As in men with chronic renal failure, the hypersecretion of prolactin in this setting appears to be autonomous, as it is resistant to maneuvers designed to stimulate or inhibit its release. It has been suggested that the elevated prolactin levels may impair hypothalamic-pituitary function and contribute to sexual dysfunction and galactorrhea in these patients. However, uremic women treated with bromocryptine rarely resume normal menses and continue to complain of galactorrhea (if present), despite normalization of the plasma prolactin concentration. Thus, factors other than hyperprolactinemia must be important in this setting .

Interventions

None listed

Sponsors

Esraa Ahmed Mohamed
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years

Inclusion criteria

* -Female patients with chronic renal failure (eGFR \<15 ml/min/1.7m2 ) on dialysis or not. * Age from 18 to 45 years old. * Married. * Sexually active during the last 6 monthes.

Exclusion criteria

* Pregnant women. * Other medical diseases ( diabetes mellitus ,cardiac disorders ,neurological disorders and other systematic diseases). * Taking medications affect sexuality function e.g. antidepressant drugs.

Design outcomes

Primary

MeasureTime frameDescription
effect of chronic renal failure in females on their sexuality functiontwo yearscompare sexuality function between female with chronic renal failure and normal female and observe difference between two groups

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026